Medpace Holdings (MEDP) Interest & Investment Income (2015 - 2026)
Medpace Holdings' (MEDP) quarterly Interest & Investment Income came in at $5.0 million in Q2 2026, up 362.52% on a YoY basis from $1.1 million in Q2 2025, and down 2.56% quarter-over-quarter from $5.1 million in Q1 2026.
Analysis
Medpace Holdings (MEDP) Interest & Investment Income (2015 - 2026) Analysis & Trends
Medpace Holdings (MEDP) has reported Interest & Investment Income for 12 consecutive years, with $5.0 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Interest & Investment Income rose 362.52% year-over-year to $5.0 million; the trailing twelve-month figure through Jun 2026 stood at $15.3 million (down 33.16% YoY), and the FY2025 full-year result was $12.8 million, down 48.87% from the prior year.
- Interest & Investment Income declined to $5.0 million in Q2 2026 per MEDP's latest filing, from $5.1 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $7.9 million in Q4 2024 and bottomed at -$1.6 million in Q3 2022.
- Historically, Interest & Investment Income has averaged $2.5 million across 5 years, with a median of $1.7 million in 2023.
- The sharpest annual moves came in 2022 and 2024: Interest & Investment Income slumped 3763.41% in 2022, then jumped 7269.52% in 2024.
- Over 5 years, Interest & Investment Income stood at -$827000.0 in 2022, then jumped by 322.97% to $1.8 million in 2023, then surged by 327.49% to $7.9 million in 2024, then slumped by 52.78% to $3.7 million in 2025, then surged by 33.96% to $5.0 million in 2026.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $5.0 million, $5.1 million, and $3.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 7.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 4.99 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 3.16 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 1.03 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | -19.30 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -210,000.00 |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | - |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 12,909.62 |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | 28,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.99 Mn |
| Mar 31, 2026 | 5.12 Mn |
| Dec 31, 2025 | 3.72 Mn |
| Sep 30, 2025 | 1.52 Mn |
| Jun 30, 2025 | 1.08 Mn |
| Mar 31, 2025 | 6.46 Mn |
| Dec 31, 2024 | 7.88 Mn |
| Sep 30, 2024 | 7.53 Mn |
| Jun 30, 2024 | 5.47 Mn |
| Mar 31, 2024 | 4.12 Mn |
| Dec 31, 2023 | 1.84 Mn |
| Sep 30, 2023 | -105,000.00 |
| Jun 30, 2023 | -1.37 Mn |
| Mar 31, 2023 | -861,000.00 |
| Dec 31, 2022 | -827,000.00 |
| Sep 30, 2022 | -1.58 Mn |
| Jun 30, 2022 | -548,000.00 |
| Mar 31, 2022 | 54,000.00 |
| Dec 31, 2021 | -23,000.00 |
| Sep 30, 2021 | -41,000.00 |